Clinical Trials Logo

Hematologic Cancer clinical trials

View clinical trials related to Hematologic Cancer.

Filter by:

NCT ID: NCT03091933 Recruiting - Clinical trials for Relapsed Multiple Myeloma

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

GLIDE
Start date: February 6, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the safety of infusing an anti-MiHA T cell line in patients suffering from an hematologic malignancy that has relapsed following hematopoietic stem cell transplantation from a matched donor.